ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,923Medicare Part D Prescriptions Filled, Including Refills

Rank: 61 out of 324

$577K Total Retail Price of All Prescriptions

Rank: 77 out of 324

423 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

12% of this provider’s 423 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

23% of this provider’s 423 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

2% of this provider’s 9,377 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
LISINOPRIL 478 354 1 3
SIMVASTATIN 461 372 2 1
LEVOTHYROXINE SODIUM 420 336 3 2
MELOXICAM 406 356 4 29
FUROSEMIDE 369 343 5 7
OMEPRAZOLE 345 275 6 6
AMLODIPINE BESYLATE 338 294 7 4
HYDROCODONE-ACETAMINOPHEN 299 201 S3 8 5
LOSARTAN POTASSIUM 231 217 9 15
METOPROLOL TARTRATE 226 191 10 14
POTASSIUM CHLORIDE 208 203 11 8
DONEPEZIL HCL 203 199 12 25
METFORMIN HCL 195 145 13 9
GABAPENTIN 176 131 14 13
ALENDRONATE SODIUM 162 151 15 24
ATORVASTATIN CALCIUM 154 127 16 12
PANTOPRAZOLE SODIUM 154 111 16 34
ATENOLOL 153 112 18 18
WARFARIN SODIUM 151 136 19 10
CYMBALTA 131 121 20 45
HYDROCHLOROTHIAZIDE 130 106 21 11
GEMFIBROZIL 128 107 22 93
FENTANYL 119 74 S2 23 64
ESCITALOPRAM OXALATE 112 80 24 54
CYCLOBENZAPRINE HCL 111 79 R 25 51
AZITHROMYCIN 109 88 26 48
LISINOPRIL-HYDROCHLOROTHIAZIDE 102 81 27 35
CITALOPRAM HBR 99 76 28 16
NAMENDA 94 94 29 31
TAMSULOSIN HCL 94 78 29 26
FLUOXETINE HCL 88 72 31 67
ENALAPRIL MALEATE 77 53 32 57
PREDNISONE 76 62 33 36
HYDRALAZINE HCL 76 75 33 113
DIGOXIN 74 66 35 40
SULFAMETHOXAZOLE-TRIMETHOPRIM 73 52 36 91
CARVEDILOL 72 63 37 22
MIRTAZAPINE 71 66 38 41
PAROXETINE HCL 71 70 38 72
ZOLPIDEM TARTRATE 65 44 40 20
NEXIUM 65 39 40 33
DOXYCYCLINE HYCLATE 64 50 42 78
CIPROFLOXACIN HCL 61 51 43 55
MORPHINE SULFATE ER 61 16 S2 43 89
AMOX TR-POTASSIUM CLAVULANATE 59 43 45 153
PROPRANOLOL HCL 59 53 45 95
ACTOS 58 49 47 131
LANTUS 57 23 48 39
SYNTHROID 56 56 49 30
BUMETANIDE 54 41 50 82
AMOXICILLIN 53 33 51 137
SINGULAIR 53 34 51 92
BISOPROLOL FUMARATE 51 48 53 175
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 24, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.